Betavivo & Diabetes
Betavivo is raising £50,000 for Diabetes UK
Betavivo is raising £50,000 for Diabetes UK with 25p from each pack of Betavivo sold being donated to the Charity.
There are over 4 million people with diabetes in the UK, and 90 per cent of them have Type 2 diabetes. For people with Type 2 diabetes, the body doesn’t produce enough insulin, the hormone that allows the glucose to enter the body’s cells to be used for fuel. This not only results in tiredness due to the lack of fuel, but also a build-up of glucose in the body causing sugar levels to rise, raising the risk of longer term damage to health.
The good news is that Type 2 diabetes can be managed by eating healthily and being active, as well as by taking medication.
How does Betavivo work?
Betavivo contains a high concentration of beta-glucan, which, when it reaches the stomach, forms a gel barrier, leading to a slower uptake of carbohydrates. It’s actually clinically proven to reduce blood sugar and insulin response after a meal**.
A spokesperson from Diabetes UK said: “We welcome this new partnership with Betavivo which will help support our vital work to fund research into diabetes, campaign on key issues, and offer education and support to more of the 4 million people in the UK who are living with diabetes.”
Read more about:
*REF: DIABETES UK
www.diabetes.org.uk – facts and stats
**LOW GI STUDY ON TYPE 2 DIABETIC MEN
Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men.
Kabir M, et al. Metabolim, 2002. 51(7): p 819-26.
The aim was to evaluate the effect of a low-glycemic index breakfast (low-GIB) rich in low-GI carbohydrates and a modest amount of soluble fibers. The effect on lipemia at a subsequent lunch, glucose and lipid metabolism in men with type 2 diabetes was studied. A total of 13 men with type 2 diabetes were randomly allocated in a double-blind cross-over design to a 4-week daily intake of a low-GI versus a high-GI breakfast separated by a 15-day washout interval. The low-GI breakfast contained 3 g oat ß-glucan. The replacement of a high-glycemic index breakfast (GIB) by a low-GIB containing 3 g oat beta glucan, lowered the postprandial plasma glucose peak, as well as plasma glucose and insulin responses after the breakfast meal. In addition, the low-GIB had reduced the cholesterol levels by 10% after 4 weeks.